Low Labor Cost ≠ Low Manufacturing Cost
Release Time:
2026-08-19
Global manufacturing is no longer a simple cycle of relocation between China and Southeast Asia. Low‑cost labor does not equate to superior overall manufacturing costs. For medical and industrial OEMs, core competitiveness lies not in cheap labor, but in a complete industrial ecosystem, comprehensive total cost, quality compliance and supply‑chain resilience.

Over the past several years, tariffs, trade policies, geopolitical uncertainty, and supply-chain diversification have encouraged many companies to move part of their manufacturing footprint from China to Southeast Asia.
But after several years of real-world experience, a more nuanced picture is emerging. Some companies are now reassessing their manufacturing strategies, and certain products, orders, and suppliers are moving back to China.
This does not mean that Southeast Asian manufacturing has failed, nor does it mean that global manufacturing is broadly “returning to China.” Rather, global manufacturing is entering a new phase — moving from simple manufacturing migration toward supply-chain rebalancing.
1. Why Are Some Manufacturing Activities Returning to China?
Southeast Asia has a clear advantage in labor costs. But manufacturing competitiveness has never been determined by labor cost alone.
- Material and component availability
- Supply-chain depth
- Engineering and technical talent
- Yield and quality costs
- Logistics and lead times
- Inventory and working capital
- Engineering-change and NPI responsiveness
- Supplier-management complexity
- Quality systems and compliance
When companies calculate the true cost of getting a product to the customer, the lowest labor cost does not necessarily translate into the lowest manufacturing cost.
Factories can be relocated. Entire industrial ecosystems are much harder to replicate.
2. Low Labor Cost Does Not Mean Low Manufacturing Cost
The real comparison should not simply be: Labor Cost. It should be: Total Manufacturing Cost.
A more complete model is:
Total Cost = Labor + Materials + Logistics + Inventory + Quality + Engineering + Management + Risk
The difference is particularly important in electronics manufacturing. A product may be assembled in Vietnam or another Southeast Asian country while its PCBs, connectors, electronic components, plastics, metal parts and other critical inputs are still sourced from China.
The message is clear: The supply chain is changing — but China has not simply disappeared from it.
3. From “China vs. Southeast Asia” to “China + Southeast Asia”
The future manufacturing question may no longer be: “China or Southeast Asia?”
Instead, it may become: “Which part of the value chain should be located where?”
Manufacturing activity | Potential regional strategy |
Critical components | China and established industrial clusters |
High-complexity PCBA | China |
NPI and engineering development | Locations with strong engineering ecosystems |
High-mix, medium/low-volume production | China |
Labor-intensive final assembly | Southeast Asia and other regions |
Country-of-origin requirements | Product- and market-specific allocation |
China-market supply | Localized China production |
Global supply chain | China + Southeast Asia + other regions |
The future is therefore more likely to be a Regional Manufacturing Network rather than a Single-Country Manufacturing Model.
The objective is not simply to move everything to another country. It is to build a more resilient and flexible manufacturing network, allocating each part of the value chain according to product requirements, customer needs, cost structure and risk.
4. What Does This Mean for Medical and Industrial OEMs?
This shift is particularly relevant to medical and industrial products.
- Higher reliability requirements
- Longer product lifecycles
- Greater engineering complexity
- More frequent engineering changes
- Stricter quality and compliance requirements
- High-mix, medium/low-volume production
For these products, the lowest labor cost is rarely the most important competitive factor.The more important question is: Can the entire manufacturing ecosystem consistently deliver the right quality, at the right time, with the right level of engineering support?
This is where China's mature manufacturing ecosystem continues to offer significant advantages.
5. Our View of the Future
We do not believe global manufacturing is simply moving through a cycle of China → Southeast Asia → China.
Instead, we see a broader structural transition:
- From location competition → ecosystem competition
- From Lowest Labor Cost → Lowest Sustainable Total Cost
- From Single-Country Manufacturing → Regional Manufacturing Networks
- From Supplier Price → Total Supply-Chain Value
For global medical and industrial OEMs, the right manufacturing partner is not simply the one offering the lowest quotation. It is the partner that can help balance Cost + Quality + Delivery + Engineering + Supply-Chain Resilience.
Ultimately, manufacturing competitiveness is not just about low cost. It is about efficiency, resilience and reliability across the entire value chain.
Hyundai
Related News